Argus 2.0 Adoption Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

Also called NCT07425236

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose device feasibility
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
KOS Inc. (from the registry)
Registry
  • NCT NCT07425236
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07425236. Non-randomized; no masking; primary purpose device feasibility. Start 2026-04-19 (anticipated); primary completion 2026-08-19 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Argus 2.0 Adoption Study
Condition
Diabetes
Condition
Diabetes Mellitus, Type 1 Diabetes
Condition
Diabetes Mellitus, Type 2
Condition
Prediabetes
Intervention (Device)
KOS Argus Continuous Glucose Monitoring System
Lead sponsor
KOS Inc. (class: industry)

Record details

Record id
cardio:ct-nct07425236
Content hash
19f1f0fb47b43b1ba568913d8b6de1caf3e959443748d24e30914cdeb66f4e90